Masayuki Namiki
Masayuki Namiki publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Atherosclerosis and Cardiovascular Diseases, Nitric Oxide and Endothelin Effects and Gastric Cancer Management and Outcomes.
- World rank
- #2,974,101 of 7,710,434 ranked researchers
- Rank in Japan
- #66,158 of 383,136
- Works
- 57
- Citations
- 1.7k
- Citations per work
- 29.8
What does Masayuki Namiki research?
Masayuki Namiki's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (8%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2747.2%
- Health Sciences2238.2%
- Medicine2238.2%
- Life Sciences814.6%
- 1Oncology14% of their works
- 2Pulmonary and Respiratory Medicine9% of their works
- 3Surgery9% of their works
- 4Molecular Biology8% of their works
- 5Immunology7% of their works
- 6Cardiology and Cardiovascular Medicine6% of their works
Research topics
- Atherosclerosis and Cardiovascular Diseases
- Nitric Oxide and Endothelin Effects
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Cancer Treatment and Pharmacology
- Angiogenesis and VEGF in Cancer
- Peroxisome Proliferator-Activated Receptors
- Pharmacogenetics and Drug Metabolism
Which keywords describe Masayuki Namiki's research?
The keywords of their largest research topics: Inflammation, Atherosclerosis, Immune Response, Oxidized LDL, Endothelial Dysfunction, Nitric Oxide, Chemotherapy and Gastric Cancer.
- endothelial progenitor cells
- Pharmacogenetics
- PPARs
- Taxanes
- Imatinib Mesylate
- Gastric Cancer
- Nitric Oxide
- Oxidized LDL
- Atherosclerosis
- Inflammation
- Immune Response
- Endothelial Dysfunction
- Chemotherapy
- Chemotherapy-Induced Peripheral Neuropathy
- Sunitinib
- Cytochrome P450
- Peroxisome Proliferator-Activated Receptors
- VEGF
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Inflammation183 topics
- Atherosclerosis152 topics
- Immune Response81 topic
- Oxidized LDL81 topic
- Endothelial Dysfunction71 topic
- Nitric Oxide71 topic
- Chemotherapy51 topic
- Gastric Cancer51 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Imatinib Mesylate41 topic
- Sunitinib41 topic
- Taxanes41 topic
- Cytochrome P45031 topic
- PPARs31 topic
- Peroxisome Proliferator-Activated Receptors31 topic
- Pharmacogenetics31 topic
- VEGF31 topic
- endothelial progenitor cells31 topic
Where does Masayuki Namiki work?
Masayuki Namiki's main affiliation in the publication record is Eisai (Japan), Japan.
How many publications and citations does Masayuki Namiki have?
OpenAlex counts 57 works and 1,696 citations for Masayuki Namiki, an h-index of 21, ranking #2,974,101 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Masayuki Namiki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.